Targeted Angiogenesis Therapy in Head and Neck Squamous Cell Carcinomas

By  

Current Angiogenesis, Vol. 1, Iss. 1, 2012-04 ,pp. : 26-38

Bentham Science Publishers

Access to resources Recommend Favorite

Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck

By Lathers D.M.R.   Achille N.J.   Young M.R.I.  

Human Immunology, Vol. 64, Iss. 12, 2003-12 ,pp. : 1160-1166

Elsevier

Access to resources Recommend Favorite

Immunological Approach in the Evaluation of Regional Lymph Nodes of Patients with Squamous Cell Carcinoma of the Head and Neck

By Verastegui E.   Morales R.   Barrera J.L.   Müeller A.   Hadden J.   Guzman B.   Meneses A.   Alfaro G.  

Clinical Immunology, Vol. 102, Iss. 1, 2002-01 ,pp. : 37-47

Academic Press

Access to resources Recommend Favorite

Efficacy of gemcitabine and cetuximab combination treatment in head and neck squamous cell carcinoma

By            

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 918-924

Spandidos Publications

Access to resources Recommend Favorite

A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck

By Hadden J.   Verastegui E.   Barrera J.L.   Kurman M.   Meneses A.   Zinser J.W.   de la Garza J.   Hadden E.  

International Immunopharmacology, Vol. 3, Iss. 8, 2003-08 ,pp. : 1073-1081

Elsevier

Access to resources Recommend Favorite